May 21, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
In patients with advanced heart failure, left ventricular assist device implantation was linked to better 2-year survival than heart transplantation when wait-list time was accounted for, researchers reported at Heart Failure 2026. However, the transplantation group had a higher survival rate at 2 years than the LVAD group when survival was measured from the time of treatment, according to the
May 21, 2026
3 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

80-year-old man undergoes heart pump implantationat private hospital in city

80-year-old man undergoes heart pump implantation at private hospital in Chennai

Creeping Gradients After TAVR Linked to Poor Longer-Term Outcomes

I’m a heart transplant recipient. I’m haunted by ‘ghost approval’ for medication I need to survive

An 80-year-old man successfully receives an LVAD implant at MGM Healthcare, improving his heart function and daily activities.

Good results reported with emergency-use and compassionate-use cases

An 80-year-old man successfully receives an LVAD implant at MGM Healthcare, improving his heart function and daily activities.

Since the introduction of durable left ventricular assist devices for advanced heart failure, management of antithrombotic…

In an early study, a tissue-engineered heart muscle product was linked to improvements in heart wall thickness, left ventricular…

An abandoned heart-failure trial offers a rare window into devices that the FDA deems "breakthrough" but never reach patients.